On November 30, 2021 BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) reported that it will host a virtual R&D Day beginning at 8:00am PT/11:00am ET today, Tuesday, November 30, 2021 (Press release, BioMarin, NOV 30, 2021, View Source [SID1234596250]). BioMarin management and external experts will provide an update to the investment community on the Company’s earlier-stage development portfolio, which is focused on translating genetic discoveries into transformative medicines.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Video Webcast and Live Q&A

Interested parties may access the video presentation that will include audio and slides of the presentations via YouTube using this link: View Source A replay of the meeting will be archived on BioMarin’s IR web site.